High-dose dual therapy bismuth-containing quadruple therapy for eradication: a systematic review and meta-analysis with trial sequential analysis

High-dose dual therapy bismuth-containing quadruple therapy for eradication: a systematic review and meta-analysis with trial sequential analysis

Background and objective: Recently, a large number of trials on proton pump inhibitor-amoxicillin-containing high-dose dual therapy (HDDT) versus bismuth-containing quadruple therapy (BQT) for Helicobacter pylori ( H. pylori ) eradication have been published with controversial and inconsistent concl...

Full description

Bibliographic Details
Main Authors:	Ben-Gang Zhou, Yu-Zhou Mei, Min Zhang, Xin Jiang, Yao-Yao Li, Yan-Bing Ding
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-01-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/17562848221147756

Similar Items

The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01)

Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022-04-01)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
by: Gisbert JP, et al.
Published: (2012-03-01)

Eradication efficacy of high-dose amoxicillin and proton pump inhibitor compared with quadruple therapy contained bismuth in the treatment of Helicobacter pylori
by: Eskandar Hajiani, et al.
Published: (2022-01-01)

Multiple Bismuth Quadruple Therapy Containing Tetracyclines Combined with Other Antibiotics and <i>Helicobacter pylori</i> Eradication Therapy
by: Yingchao Sun, et al.
Published: (2022-11-01)

Generalization and safety of the second-line levofl oxacin or Bismuth-based quadruple therapy for Helicobacter eradication
by: Bowen Hu, et al.
Published: (2023-11-01)

Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy bismuth-containing quadruple therapy for infection: a multicenter, randomized controlled clinical trial
by: Hao Mei, et al.
Published: (2022-12-01)

High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of helicobacter pylori infection: A meta-analysis of randomized controlled trials
by: Chong Zhang, et al.
Published: (2023-01-01)

Efficacy analysis of empirical bismuth quadruple therapy, high-dose dual therapy, and resistance gene-based triple therapy as a first-line Helicobacter pylori eradication regimen – An open-label, randomized trial
by: Jiang Xin, et al.
Published: (2023-07-01)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01)

Effects of 14-days bismuth- and tetracycline-containing quadruple therapy with concomitant regimen for the first line Helicobacter pylori eradication
by: Arash Kazemi, et al.
Published: (2023-09-01)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
by: Fahad Alsohaibani, et al.
Published: (2020-01-01)

Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01)

High-dose dual therapy versus bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection – A review of the strengths, weaknesses, and proposed solutions
by: Chi-Tan Hu
Published: (2022-01-01)

Minocycline/Amoxicillin-Based Bismuth Quadruple Therapy for <i>Helicobacter pylori</i> Eradication: A Pilot Study
by: Senlin You, et al.
Published: (2024-02-01)

The efficacy and safety of in addition to antofloxacin-based bismuth quadruple therapy for eradication: a single-center, prospective randomized-control study
by: Xiao-Jian He, et al.
Published: (2023-01-01)

Comparison of eradication rates of moxifloxacin–rifabutin triple therapy and bismuth quadruple therapy as second‐line regimens in patients with peptic ulcers
by: Chang Min Lee, et al.
Published: (2022-09-01)

A randomized clinical trial comparing triple therapy versus non-bismuth based quadruple therapy for the eradication of Helicobacter Pylori in Kuwait
by: Ahmad Alfadhli, et al.
Published: (2022-01-01)

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota
by: S. Prast-Nielsen, et al.
Published: (2019-11-01)

Sequential therapy versus quadruple therapy for Helicobacter pylori eradication: A prospective double‐blinded randomized controlled trial
by: Elham Tabesh, et al.
Published: (2024-01-01)

Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials
by: Ben-Gang Zhou, et al.
Published: (2023-01-01)

Comparison of Sequential, Hybrid, and Quadruple Therapy Protocols in Helicobacter pylori Eradication: A Single-Center Study
by: Ersin Kuloğlu, et al.
Published: (2022-10-01)

Efficacy and safety of probiotic-supplemented bismuth quadruple therapy for the treatment of infection: a systematic review and meta-analysis
by: Gaoyan Yao, et al.
Published: (2023-10-01)

The effect of supplementing with Saccharomyces boulardii on bismuth quadruple therapy for eradicating Helicobacter pylori: a systematic review and meta-analysis of randomized controlled trials
by: Yin Chen, et al.
Published: (2024-04-01)

Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
by: Chang Seok Bang, et al.
Published: (2020-09-01)

Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates
by: Kiwon Shin, et al.
Published: (2021-07-01)

A Simplified Low-Dose 10-Day Quadruple Therapy with a Galenic Formulation of Bismuth Salicylate Is Highly Effective for <i>Helicobacter pylori</i> Eradication
by: Maria Pina Dore, et al.
Published: (2023-01-01)

Lactobacillus rhamnosus GG supplementation on eradication rate and dyspepsia in Helicobacter pylori infection treated with three-in-one bismuth quadruple therapy
by: Paride Marinelli, et al.
Published: (2022-12-01)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
by: Mohammadreza Seyyedmajidi, et al.
Published: (2019-03-01)

Helicobacter Pylori Eradication in Renal Recipient: Triple or Quadruple Therapy?
by: Seyed Mousal Reza Hosseini, et al.
Published: (2014-04-01)

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line <em>Helicobacter pylori</em> Eradication: An Intervention Study in Southern Italy
by: Giuseppe Losurdo, et al.
Published: (2022-01-01)

The Effect of Quadruple Therapy with Polaprezinc or Bismuth on Gut Microbiota after <i>Helicobacter pylori</i> Eradication: A Randomized Controlled Trial
by: Dingkun Wu, et al.
Published: (2022-11-01)

Susceptibility-Guided Therapy vs. Bismuth-Containing Quadruple Therapy as the First-Line Treatment for Helicobacter pylori Infection: A Systematic Review and Meta-Analysis
by: Yaobin Ouyang, et al.
Published: (2022-03-01)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
by: Eskandar Hajiani, et al.
Published: (2018-10-01)

Bismuth, An Indispensable Component of Helicobacter pylori Eradication Therapy
by: Kyung Ho Song
Published: (2023-06-01)

Seven Days of Bismuth-Based Quadruple Therapy Is as Effective for the First-Line Treatment of Clarithromycin-Resistant Confirmed <i>Helicobacter pylori</i> Infection as 14 Days of Bismuth-Based Quadruple Therapy
by: Sang-Gon Moon, et al.
Published: (2022-07-01)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
by: Hung KT, et al.
Published: (2021-03-01)

Sequential therapy for eradication: the time is now!
by: Dino Vaira, et al.
Published: (2009-11-01)

Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori
by: Murat Kekilli, et al.
Published: (2016-01-01)

Efficacy of Ecabet Sodium for Eradication with Sequential Therapy
by: Seol So, et al.
Published: (2019-03-01)